JACQUELYN VAN WATERS: Open Payments
NPI 1699211631 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 96 payments from 19 companies in 2025. Trend: 2023 $1,568 · 2024 $1,372 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $294 |
| Otsuka America Pharmaceutical, Inc. | 8 | $180 |
| Corium, LLC | 12 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $143 |
| Lilly USA, LLC | 4 | $75 |
| Novo Nordisk Inc | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Tris Pharma Inc | 2 | $33 |
Products named: REXULTI, UBRELVY, Azstarys, CAPLYTA, VRAYLAR, MOUNJARO, Jornay PM, Wegovy.
Industry payments across KY — which companies pay providers there.
